Cargando…

Prevalence, Clinical Severity, and Seasonality of Adenovirus 40/41, Astrovirus, Sapovirus, and Rotavirus Among Young Children With Moderate-to-Severe Diarrhea: Results From the Vaccine Impact on Diarrhea in Africa (VIDA) Study

BACKGROUND: While rotavirus causes severe diarrheal disease in children aged <5 years, data on other viral causes in sub-Saharan Africa are limited. METHODS: In the Vaccine Impact on Diarrhea in Africa study (2015–2018), we analyzed stool from children aged 0–59 months with moderate-to-severe dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Keita, Adama Mamby, Doh, Sanogo, Sow, Samba O, Powell, Helen, Omore, Richard, Jahangir Hossain, M, Ogwel, Billy, Ochieng, John B, Jones, Joquina Chiquita M, Zaman, Syed M A, Awuor, Alex O, Juma, Jane, Nasrin, Dilruba, Liu, Jie, Traoré, Awa, Onwuchekwa, Uma, Badji, Henry, Sarwar, Golam, Antonio, Martin, Houpt, Eric R, Tennant, Sharon M, Kasumba, Irene N, Jamka, Leslie P, Roose, Anna, Platts-Mills, James A, Verani, Jennifer R, Tate, Jacqueline E, Parashar, Umesh D, Neuzil, Kathleen M, Kotloff, Karen L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116545/
https://www.ncbi.nlm.nih.gov/pubmed/37074439
http://dx.doi.org/10.1093/cid/ciad060
_version_ 1785028446909366272
author Keita, Adama Mamby
Doh, Sanogo
Sow, Samba O
Powell, Helen
Omore, Richard
Jahangir Hossain, M
Ogwel, Billy
Ochieng, John B
Jones, Joquina Chiquita M
Zaman, Syed M A
Awuor, Alex O
Juma, Jane
Nasrin, Dilruba
Liu, Jie
Traoré, Awa
Onwuchekwa, Uma
Badji, Henry
Sarwar, Golam
Antonio, Martin
Houpt, Eric R
Tennant, Sharon M
Kasumba, Irene N
Jamka, Leslie P
Roose, Anna
Platts-Mills, James A
Verani, Jennifer R
Tate, Jacqueline E
Parashar, Umesh D
Neuzil, Kathleen M
Kotloff, Karen L
author_facet Keita, Adama Mamby
Doh, Sanogo
Sow, Samba O
Powell, Helen
Omore, Richard
Jahangir Hossain, M
Ogwel, Billy
Ochieng, John B
Jones, Joquina Chiquita M
Zaman, Syed M A
Awuor, Alex O
Juma, Jane
Nasrin, Dilruba
Liu, Jie
Traoré, Awa
Onwuchekwa, Uma
Badji, Henry
Sarwar, Golam
Antonio, Martin
Houpt, Eric R
Tennant, Sharon M
Kasumba, Irene N
Jamka, Leslie P
Roose, Anna
Platts-Mills, James A
Verani, Jennifer R
Tate, Jacqueline E
Parashar, Umesh D
Neuzil, Kathleen M
Kotloff, Karen L
author_sort Keita, Adama Mamby
collection PubMed
description BACKGROUND: While rotavirus causes severe diarrheal disease in children aged <5 years, data on other viral causes in sub-Saharan Africa are limited. METHODS: In the Vaccine Impact on Diarrhea in Africa study (2015–2018), we analyzed stool from children aged 0–59 months with moderate-to-severe diarrhea (MSD) and without diarrhea (controls) in Kenya, Mali, and The Gambia using quantitative polymerase chain reaction. We derived the attributable fraction (AFe) based on the association between MSD and the pathogen, accounting for other pathogens, site, and age. A pathogen was attributable if the AFe was ≥0.5. The severity of attributable MSD was defined by a modified Vesikari score (mVS). Monthly cases were plotted against temperature and rainfall to assess seasonality. RESULTS: Among 4840 MSD cases, proportions attributed to rotavirus, adenovirus 40/41, astrovirus, and sapovirus were 12.6%, 2.7%, 2.9%, and 1.9%, respectively. Attributable rotavirus, adenovirus 40/41, and astrovirus MSD cases occurred at all sites, with mVS of 11, 10, and 7, respectively. MSD cases attributable to sapovirus occurred in Kenya, with mVS of 9. Astrovirus and adenovirus 40/41 peaked during the rainy season in The Gambia, while rotavirus peaked during the dry season in Mali and The Gambia. CONCLUSIONS: In sub-Saharan Africa, rotavirus was the most common cause of MSD; adenovirus 40/41, astrovirus, and sapovirus contributed to a lesser extent among children aged <5 years. Rotavirus- and adenovirus 40/41-attributable MSD were most severe. Seasonality varied by pathogen and location. Efforts to increase the coverage of rotavirus vaccines and to improve prevention and treatment for childhood diarrhea should continue.
format Online
Article
Text
id pubmed-10116545
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-101165452023-04-21 Prevalence, Clinical Severity, and Seasonality of Adenovirus 40/41, Astrovirus, Sapovirus, and Rotavirus Among Young Children With Moderate-to-Severe Diarrhea: Results From the Vaccine Impact on Diarrhea in Africa (VIDA) Study Keita, Adama Mamby Doh, Sanogo Sow, Samba O Powell, Helen Omore, Richard Jahangir Hossain, M Ogwel, Billy Ochieng, John B Jones, Joquina Chiquita M Zaman, Syed M A Awuor, Alex O Juma, Jane Nasrin, Dilruba Liu, Jie Traoré, Awa Onwuchekwa, Uma Badji, Henry Sarwar, Golam Antonio, Martin Houpt, Eric R Tennant, Sharon M Kasumba, Irene N Jamka, Leslie P Roose, Anna Platts-Mills, James A Verani, Jennifer R Tate, Jacqueline E Parashar, Umesh D Neuzil, Kathleen M Kotloff, Karen L Clin Infect Dis VIDA Supplement BACKGROUND: While rotavirus causes severe diarrheal disease in children aged <5 years, data on other viral causes in sub-Saharan Africa are limited. METHODS: In the Vaccine Impact on Diarrhea in Africa study (2015–2018), we analyzed stool from children aged 0–59 months with moderate-to-severe diarrhea (MSD) and without diarrhea (controls) in Kenya, Mali, and The Gambia using quantitative polymerase chain reaction. We derived the attributable fraction (AFe) based on the association between MSD and the pathogen, accounting for other pathogens, site, and age. A pathogen was attributable if the AFe was ≥0.5. The severity of attributable MSD was defined by a modified Vesikari score (mVS). Monthly cases were plotted against temperature and rainfall to assess seasonality. RESULTS: Among 4840 MSD cases, proportions attributed to rotavirus, adenovirus 40/41, astrovirus, and sapovirus were 12.6%, 2.7%, 2.9%, and 1.9%, respectively. Attributable rotavirus, adenovirus 40/41, and astrovirus MSD cases occurred at all sites, with mVS of 11, 10, and 7, respectively. MSD cases attributable to sapovirus occurred in Kenya, with mVS of 9. Astrovirus and adenovirus 40/41 peaked during the rainy season in The Gambia, while rotavirus peaked during the dry season in Mali and The Gambia. CONCLUSIONS: In sub-Saharan Africa, rotavirus was the most common cause of MSD; adenovirus 40/41, astrovirus, and sapovirus contributed to a lesser extent among children aged <5 years. Rotavirus- and adenovirus 40/41-attributable MSD were most severe. Seasonality varied by pathogen and location. Efforts to increase the coverage of rotavirus vaccines and to improve prevention and treatment for childhood diarrhea should continue. Oxford University Press 2023-04-19 /pmc/articles/PMC10116545/ /pubmed/37074439 http://dx.doi.org/10.1093/cid/ciad060 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle VIDA Supplement
Keita, Adama Mamby
Doh, Sanogo
Sow, Samba O
Powell, Helen
Omore, Richard
Jahangir Hossain, M
Ogwel, Billy
Ochieng, John B
Jones, Joquina Chiquita M
Zaman, Syed M A
Awuor, Alex O
Juma, Jane
Nasrin, Dilruba
Liu, Jie
Traoré, Awa
Onwuchekwa, Uma
Badji, Henry
Sarwar, Golam
Antonio, Martin
Houpt, Eric R
Tennant, Sharon M
Kasumba, Irene N
Jamka, Leslie P
Roose, Anna
Platts-Mills, James A
Verani, Jennifer R
Tate, Jacqueline E
Parashar, Umesh D
Neuzil, Kathleen M
Kotloff, Karen L
Prevalence, Clinical Severity, and Seasonality of Adenovirus 40/41, Astrovirus, Sapovirus, and Rotavirus Among Young Children With Moderate-to-Severe Diarrhea: Results From the Vaccine Impact on Diarrhea in Africa (VIDA) Study
title Prevalence, Clinical Severity, and Seasonality of Adenovirus 40/41, Astrovirus, Sapovirus, and Rotavirus Among Young Children With Moderate-to-Severe Diarrhea: Results From the Vaccine Impact on Diarrhea in Africa (VIDA) Study
title_full Prevalence, Clinical Severity, and Seasonality of Adenovirus 40/41, Astrovirus, Sapovirus, and Rotavirus Among Young Children With Moderate-to-Severe Diarrhea: Results From the Vaccine Impact on Diarrhea in Africa (VIDA) Study
title_fullStr Prevalence, Clinical Severity, and Seasonality of Adenovirus 40/41, Astrovirus, Sapovirus, and Rotavirus Among Young Children With Moderate-to-Severe Diarrhea: Results From the Vaccine Impact on Diarrhea in Africa (VIDA) Study
title_full_unstemmed Prevalence, Clinical Severity, and Seasonality of Adenovirus 40/41, Astrovirus, Sapovirus, and Rotavirus Among Young Children With Moderate-to-Severe Diarrhea: Results From the Vaccine Impact on Diarrhea in Africa (VIDA) Study
title_short Prevalence, Clinical Severity, and Seasonality of Adenovirus 40/41, Astrovirus, Sapovirus, and Rotavirus Among Young Children With Moderate-to-Severe Diarrhea: Results From the Vaccine Impact on Diarrhea in Africa (VIDA) Study
title_sort prevalence, clinical severity, and seasonality of adenovirus 40/41, astrovirus, sapovirus, and rotavirus among young children with moderate-to-severe diarrhea: results from the vaccine impact on diarrhea in africa (vida) study
topic VIDA Supplement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116545/
https://www.ncbi.nlm.nih.gov/pubmed/37074439
http://dx.doi.org/10.1093/cid/ciad060
work_keys_str_mv AT keitaadamamamby prevalenceclinicalseverityandseasonalityofadenovirus4041astrovirussapovirusandrotavirusamongyoungchildrenwithmoderatetoseverediarrhearesultsfromthevaccineimpactondiarrheainafricavidastudy
AT dohsanogo prevalenceclinicalseverityandseasonalityofadenovirus4041astrovirussapovirusandrotavirusamongyoungchildrenwithmoderatetoseverediarrhearesultsfromthevaccineimpactondiarrheainafricavidastudy
AT sowsambao prevalenceclinicalseverityandseasonalityofadenovirus4041astrovirussapovirusandrotavirusamongyoungchildrenwithmoderatetoseverediarrhearesultsfromthevaccineimpactondiarrheainafricavidastudy
AT powellhelen prevalenceclinicalseverityandseasonalityofadenovirus4041astrovirussapovirusandrotavirusamongyoungchildrenwithmoderatetoseverediarrhearesultsfromthevaccineimpactondiarrheainafricavidastudy
AT omorerichard prevalenceclinicalseverityandseasonalityofadenovirus4041astrovirussapovirusandrotavirusamongyoungchildrenwithmoderatetoseverediarrhearesultsfromthevaccineimpactondiarrheainafricavidastudy
AT jahangirhossainm prevalenceclinicalseverityandseasonalityofadenovirus4041astrovirussapovirusandrotavirusamongyoungchildrenwithmoderatetoseverediarrhearesultsfromthevaccineimpactondiarrheainafricavidastudy
AT ogwelbilly prevalenceclinicalseverityandseasonalityofadenovirus4041astrovirussapovirusandrotavirusamongyoungchildrenwithmoderatetoseverediarrhearesultsfromthevaccineimpactondiarrheainafricavidastudy
AT ochiengjohnb prevalenceclinicalseverityandseasonalityofadenovirus4041astrovirussapovirusandrotavirusamongyoungchildrenwithmoderatetoseverediarrhearesultsfromthevaccineimpactondiarrheainafricavidastudy
AT jonesjoquinachiquitam prevalenceclinicalseverityandseasonalityofadenovirus4041astrovirussapovirusandrotavirusamongyoungchildrenwithmoderatetoseverediarrhearesultsfromthevaccineimpactondiarrheainafricavidastudy
AT zamansyedma prevalenceclinicalseverityandseasonalityofadenovirus4041astrovirussapovirusandrotavirusamongyoungchildrenwithmoderatetoseverediarrhearesultsfromthevaccineimpactondiarrheainafricavidastudy
AT awuoralexo prevalenceclinicalseverityandseasonalityofadenovirus4041astrovirussapovirusandrotavirusamongyoungchildrenwithmoderatetoseverediarrhearesultsfromthevaccineimpactondiarrheainafricavidastudy
AT jumajane prevalenceclinicalseverityandseasonalityofadenovirus4041astrovirussapovirusandrotavirusamongyoungchildrenwithmoderatetoseverediarrhearesultsfromthevaccineimpactondiarrheainafricavidastudy
AT nasrindilruba prevalenceclinicalseverityandseasonalityofadenovirus4041astrovirussapovirusandrotavirusamongyoungchildrenwithmoderatetoseverediarrhearesultsfromthevaccineimpactondiarrheainafricavidastudy
AT liujie prevalenceclinicalseverityandseasonalityofadenovirus4041astrovirussapovirusandrotavirusamongyoungchildrenwithmoderatetoseverediarrhearesultsfromthevaccineimpactondiarrheainafricavidastudy
AT traoreawa prevalenceclinicalseverityandseasonalityofadenovirus4041astrovirussapovirusandrotavirusamongyoungchildrenwithmoderatetoseverediarrhearesultsfromthevaccineimpactondiarrheainafricavidastudy
AT onwuchekwauma prevalenceclinicalseverityandseasonalityofadenovirus4041astrovirussapovirusandrotavirusamongyoungchildrenwithmoderatetoseverediarrhearesultsfromthevaccineimpactondiarrheainafricavidastudy
AT badjihenry prevalenceclinicalseverityandseasonalityofadenovirus4041astrovirussapovirusandrotavirusamongyoungchildrenwithmoderatetoseverediarrhearesultsfromthevaccineimpactondiarrheainafricavidastudy
AT sarwargolam prevalenceclinicalseverityandseasonalityofadenovirus4041astrovirussapovirusandrotavirusamongyoungchildrenwithmoderatetoseverediarrhearesultsfromthevaccineimpactondiarrheainafricavidastudy
AT antoniomartin prevalenceclinicalseverityandseasonalityofadenovirus4041astrovirussapovirusandrotavirusamongyoungchildrenwithmoderatetoseverediarrhearesultsfromthevaccineimpactondiarrheainafricavidastudy
AT houptericr prevalenceclinicalseverityandseasonalityofadenovirus4041astrovirussapovirusandrotavirusamongyoungchildrenwithmoderatetoseverediarrhearesultsfromthevaccineimpactondiarrheainafricavidastudy
AT tennantsharonm prevalenceclinicalseverityandseasonalityofadenovirus4041astrovirussapovirusandrotavirusamongyoungchildrenwithmoderatetoseverediarrhearesultsfromthevaccineimpactondiarrheainafricavidastudy
AT kasumbairenen prevalenceclinicalseverityandseasonalityofadenovirus4041astrovirussapovirusandrotavirusamongyoungchildrenwithmoderatetoseverediarrhearesultsfromthevaccineimpactondiarrheainafricavidastudy
AT jamkalesliep prevalenceclinicalseverityandseasonalityofadenovirus4041astrovirussapovirusandrotavirusamongyoungchildrenwithmoderatetoseverediarrhearesultsfromthevaccineimpactondiarrheainafricavidastudy
AT rooseanna prevalenceclinicalseverityandseasonalityofadenovirus4041astrovirussapovirusandrotavirusamongyoungchildrenwithmoderatetoseverediarrhearesultsfromthevaccineimpactondiarrheainafricavidastudy
AT plattsmillsjamesa prevalenceclinicalseverityandseasonalityofadenovirus4041astrovirussapovirusandrotavirusamongyoungchildrenwithmoderatetoseverediarrhearesultsfromthevaccineimpactondiarrheainafricavidastudy
AT veranijenniferr prevalenceclinicalseverityandseasonalityofadenovirus4041astrovirussapovirusandrotavirusamongyoungchildrenwithmoderatetoseverediarrhearesultsfromthevaccineimpactondiarrheainafricavidastudy
AT tatejacquelinee prevalenceclinicalseverityandseasonalityofadenovirus4041astrovirussapovirusandrotavirusamongyoungchildrenwithmoderatetoseverediarrhearesultsfromthevaccineimpactondiarrheainafricavidastudy
AT parasharumeshd prevalenceclinicalseverityandseasonalityofadenovirus4041astrovirussapovirusandrotavirusamongyoungchildrenwithmoderatetoseverediarrhearesultsfromthevaccineimpactondiarrheainafricavidastudy
AT neuzilkathleenm prevalenceclinicalseverityandseasonalityofadenovirus4041astrovirussapovirusandrotavirusamongyoungchildrenwithmoderatetoseverediarrhearesultsfromthevaccineimpactondiarrheainafricavidastudy
AT kotloffkarenl prevalenceclinicalseverityandseasonalityofadenovirus4041astrovirussapovirusandrotavirusamongyoungchildrenwithmoderatetoseverediarrhearesultsfromthevaccineimpactondiarrheainafricavidastudy